【24h】

情志相胜疗法在慢性阻塞性肺病患者中的应用

机译:情志相胜疗法在慢性阻塞性肺病患者中的应用

获取原文
       

摘要

Abstract:Objective To investigate the effect of emotional restrictive therapy on anxiety and depression status and pulmonary function in patients with chronic obstructive pulmonary disease(COPD). Methods Totally 100 COPD patients were randomly divided into treatment and control group, with 50 cases in each group. Both two groups received routine nursing care during treatment, and the emotional restrictive therapy was provided to patients in the treatment group. The improvement in self-rating depression scale(SDS), self-rating anxiety scale(SAS)and pulmonary function were compared between two groups. Results Patients in the treatment achieved a lower score of SAS and SDS compared with those in the control group after intervention(P0.01). The predicted forced expiratory volume in 1 sec(FEV1%)and the ratio of FEV1 to forced vital capacity(FVC)were increased in both two group after nursing intervention, and were higher in the treatment group than those in the control group(P0.05 or P0.01). Conclusion Emotional restrictive therapy can relieve the anxiety and depression of the patients, and to improve the treatment compliance as well as respiratory function of COPD patients.
机译:摘要:目的探讨情绪限制疗法对慢性阻塞性肺疾病(COPD)患者焦虑,抑郁状态及肺功能的影响。方法将100例COPD患者随机分为治疗组和对照组,每组50例。两组均在治疗期间接受常规护理,并向治疗组患者提供了情感限制疗法。比较两组自评抑郁量表(SDS),自评焦虑量表(SAS)和肺功能的改善情况。结果干预组患者SAS和SDS评分均低于对照组(P <0.01)。护理干预后,两组预测的1秒强迫呼气量(FEV1%)和FEV1与强迫肺活量(FVC)的比率均增加,治疗组高于对照组(P < 0.05或P <0.01)。结论情绪限制性疗法可减轻COPD患者的焦虑和抑郁情绪,改善其治疗依从性和呼吸功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号